How to Get Right Dose in Coronary CTA scan at Primary Hospital

来源 :中国中西医结合学会医学影像专业委员会第十五次全国学术大会暨上海市中西医结合学会医学影像专业委员会2017年学术年会 | 被引量 : 0次 | 上传用户:QINQINXIAOTIANXIN
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
With the progress of technology,CT equipment with wider detector and faster rotation speed are more and more used in clinical application,but in basic level medical institutions,or the primary hospital,the most use scanner to do a coronary CTA study are still 64/128 slices CT equipment,the detector wide is about 32-40mm,and the rotation speed is generally 0.3-0.4s.
其他文献
Objective: Pyruvatekinase M2 (PKM2) is the key enzyme in Warburg effect and was reported to be involved in metabolic pathways of tumor cells response to chemotherapeutic drugs recently.
Objective: Photothermal therapy (PTT) has emerge as a promising way to treat cancer with minimal invasion and high selectivity.The purpose of this study was to synthesis gold nanoprisms (GNPs) as a ne
Objective: It is a widely known fact that male breast cancer(MBC) is a rare disease compared with female breast cancer (FBC) and account for only 1% of all breast cancers.
目的: Sirt7,as one of the seven Sirtuin family members,which plays distinct roles in cancer progression,is bringing emerging attention due to its oncogenic characteristic.
目的: Toexamine the prognostic significance of SHP-1 in breast cancer, its role in regulationofbreast cancer cell growth and metastasis, and the underlying mechanisms.
目的: We present a case of ALK gene translocation-squamous cell lung cancer which experienced a remarkable tumor response to crizotinib after failure of prior chemoradiotherapy.
目的:探讨在65例高龄晚期非小细胞肺癌患者中埃克替尼的疗效和安全性。方法:经病理学或细胞学证实≥75岁的ⅢB-Ⅳ期非小细胞肺癌患者,口服埃克替尼125mg每天3次,直至疾病进展或者出现严重不良反应,评价疗效及不良反应。
目的:Ⅲ期临床试验(ICOGEN)显示,埃克替尼在ⅢB/Ⅳ期非小细胞肺癌亚洲人群的安全性和有效性不劣于吉非替尼。本项回顾性研究目的为评估埃克替尼在EGFR状态未知且首月试用有效人群和EGFR敏感突变(19外显子缺失、21号外显子L858R突变)人群的有效性和安全性。
目的:介绍肺癌患者术中应用榄香烯乳进行冲洗的经验。方法:实验组收集北京胸科医院胸外一科肺癌患者30例对照组选择同期术中未进行榄香烯乳冲洗的肺癌患者105例。患者切除肿瘤后使用金港榄香烯冲洗。
目的:本研究的主要目的:通过分析广泛期小细胞肺癌患者治疗前的实验室指标及初次评效结果与疾病进展和总生存的关系,得出影响其预后的因素。方法:本研究回顾性地分析了自2008年3月至2014年9月于中国医科大学附属第一医院肿瘤内科住院治疗的患者96例。